Zimbabwe has rejected a significant US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years because of Washington's request for sensitive information.
This rejection became public after a government memo dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the agreement was "lopsided".
A government spokesman later clarified that the US was demanding access to health data for research and profit but was not willing to guarantee the resulting advantages from any future medical innovations.
"We must now begin the difficult and regrettable process of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged continued dialogue to secure a agreement suitable to both sides so the country's critical HIV programme can proceed.
Broader Context
This rejection follows a similar situation in neighbouring Kenya, where a high court halted a similar deal with the US after legal challenges were filed about the safety of citizens' medical information.
Since returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump claimed its expenditure was "wasteful" and his administration was seeking government-to-government deals to enhance openness and accountability.
Based on reports, Sixteen African countries have to date agreed to these new health pacts, representing more than $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration might have yielded significant advantages for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy through US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, without any equivalent assurance of access to any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," his statement read.
"Put simply, our country would supply the basic resources for medical research without any certainty that the end products would be available to our citizens if a future health crisis arise."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the global health body and its push of one-on-one health agreements were upending frameworks previously set up via the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.
"This framework is intended to ensure that when a nation provides its information, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the capability to create them."
These objections regarding the US deal "are not meant as hostility towards the US," he added.
"We welcome continued discussions with our US partners on how future collaboration might be designed in a manner that honours the independence and interests of each country."
Health Experts Reaction
A leading public health body said it acknowledged the official position, but suggested that negotiations must proceed considering a large portion of the nation's Aids initiatives relied on foreign aid.
"In cases where technical issues arise, such as those involving data governance or agreement terms, these can frequently be resolved via technical clarification and negotiated safeguards," the group commented.
The situation underscores the ongoing tensions between receiving much-needed foreign assistance and safeguarding local interests in an increasingly interconnected world.